MAMMOTH BIOSCIENCES INC.

Company Overview

Founded in 2017, Mammoth Biosciences is a biotech company that has developed the first CRISPR-based detection platform capable of sensing any biomarker or disease with DNA/RNA. The company provides services to various sectors including healthcare, environmental monitoring, agriculture, and biodefense. With expertise spanning the intersection of data analytics and molecular biology, Mammoth Bioscience is on a mission to leverage the power of CRISPR to democratize disease detection by bringing accurate and affordable testing out of the laboratory and into the point-of-care and by providing access to various tests for biosensing in other industries such as agriculture, manufacturing, and forensics. The company’s funding was led by top investors and includes Mayfield, NFX, 8VC, AME Cloud, Wireframe, Kairos, and Boom Capital.

Company's Business Segments

• CRISPR systems : This segment includes Mammoth Biosciences focused on Leveraging its proprietary Ultracompact CRISPR Systems to develop Long-Term Curative Therapies, Permanent cures through in vivo CRISPR-Based Precision Editing, Discovering and Engineering novel CRISPR Systems and Technologies, Molecular Diagnostics, Enabling Limitless Testing Possibilities.